dahae
2022-01-13
Qqq
Aesthetics Firm Suneva Is in Talks for Viveon Health SPAC Deal<blockquote>美容公司Suneva正在就Viveon Health SPAC交易进行谈判</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":694257889,"tweetId":"694257889","gmtCreate":1642003502104,"gmtModify":1642003502285,"author":{"id":3560092322694803,"idStr":"3560092322694803","authorId":3560092322694803,"authorIdStr":"3560092322694803","name":"dahae","avatar":"https://static.tigerbbs.com/137beae1f6048901843924ba46796740","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":13,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Qqq</p></body></html>","htmlText":"<html><head></head><body><p>Qqq</p></body></html>","text":"Qqq","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/694257889","repostId":1199219279,"repostType":4,"repost":{"id":"1199219279","kind":"news","pubTimestamp":1641998773,"share":"https://www.laohu8.com/m/news/1199219279?lang=zh_CN&edition=full","pubTime":"2022-01-12 22:46","market":"us","language":"en","title":"Aesthetics Firm Suneva Is in Talks for Viveon Health SPAC Deal<blockquote>美容公司Suneva正在就Viveon Health SPAC交易进行谈判</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1199219279","media":"Bloomberg","summary":"(Bloomberg) -- Suneva Medical Inc., which sells beauty and anti-aging products to doctors’ offices, ","content":"<p><html><head></head><body>(Bloomberg) -- Suneva Medical Inc., which sells beauty and anti-aging products to doctors’ offices, has agreed to go public through a merger with blank-check company Viveon Health Acquisition Corp.</p><p><blockquote><html><head></head><body>（彭博）-向医生办公室销售美容和抗衰老产品的Suneva Medical Inc.已同意通过与空白支票公司Viveon Health Acquisition Corp.合并上市。</body></html></blockquote></p><p>The deal values the combined company at about $511 million including debt, according to a statement Wednesday that confirmed an earlier Bloomberg News report. Existing Suneva backers will invest $10 million in a private investment in public equity deal, according to Chief Executive Officer Pat Altavilla.</p><p><blockquote>根据周三的一份声明，该交易对合并后公司的估值约为5.11亿美元，包括债务，该声明证实了彭博新闻社早些时候的报道。Suneva首席执行官帕特·阿尔塔维拉(Pat Altavilla)表示，Suneva现有支持者将投资1000万美元进行私募股权交易。</blockquote></p><p>The combined company will operate as Suneva Medical and trade on the New York Stock Exchange under the symbol RNEW, according to the statement.</p><p><blockquote>声明称，合并后的公司将在纽约证券交易所以Suneva Medical and trade的名义运营，代码为RNEW。</blockquote></p><p>“It’s a wonderful way for Suneva to become fully capitalized to take advantage of the remarkable capabilities of the capital markets and to grow the business the way we intend to,” Altavilla said in an interview.</p><p><blockquote>阿尔塔维拉在接受采访时表示：“对于Suneva来说，这是一个充分资本化的好方法，可以利用资本市场的卓越能力，并按照我们打算的方式发展业务。”</blockquote></p><p>Suneva expects to grow by developing new products like a hair-restoration offering, acquiring businesses and catering to more men and millenials, she said.</p><p><blockquote>她说，Suneva希望通过开发头发修复产品等新产品、收购企业以及迎合更多男性和千禧一代来实现增长。</blockquote></p><p>Suneva specializes in so-called regenerative aesthetics that use the body’s own collagen to improve the skin’s appearance. Its biggest product is Bellafill, a Food and Drug Administration-approved dermal filler that is advertised to “smooth smile lines” and reduce the appearance of acne scars. Its products and procedures, all of which Altavilla said have a “biostimulatory component” are sold into medical offices and conducted by doctors, nurses or nurse practitioners. It has about 1600 customers, she said.</p><p><blockquote>Suneva专注于所谓的再生美学，利用身体自身的胶原蛋白来改善皮肤的外观。其最大的产品是Bellafill，这是一种美国食品药品监督管理局批准的真皮填充物，宣传可以“抚平笑纹”并减少痤疮疤痕的出现。阿尔塔维拉表示，其产品和程序都含有“生物刺激成分”，这些产品和程序都出售给医疗办公室，并由医生、护士或执业护士进行。她说，它有大约1600名顾客。</blockquote></p><p>Viveon Health Acquisition, a special purpose acquisition company, or SPAC, raised $201 million in its initial public offering in 2020.</p><p><blockquote>Viveon Health Acquisition是一家特殊目的收购公司(SPAC)，在2020年首次公开募股中筹集了2.01亿美元。</blockquote></p><p>“People are looking toward more natural solutions,” Altavilla said. “The regenerative properties of these procedures allow them to have better longer-lasting results.”</p><p><blockquote>“人们正在寻找更自然的解决方案，”阿尔塔维拉说。“这些程序的再生特性使它们能够获得更好、更持久的结果。”</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aesthetics Firm Suneva Is in Talks for Viveon Health SPAC Deal<blockquote>美容公司Suneva正在就Viveon Health SPAC交易进行谈判</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAesthetics Firm Suneva Is in Talks for Viveon Health SPAC Deal<blockquote>美容公司Suneva正在就Viveon Health SPAC交易进行谈判</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Bloomberg</strong><span class=\"h-time small\">2022-01-12 22:46</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><head></head><body>(Bloomberg) -- Suneva Medical Inc., which sells beauty and anti-aging products to doctors’ offices, has agreed to go public through a merger with blank-check company Viveon Health Acquisition Corp.</p><p><blockquote><html><head></head><body>（彭博）-向医生办公室销售美容和抗衰老产品的Suneva Medical Inc.已同意通过与空白支票公司Viveon Health Acquisition Corp.合并上市。</body></html></blockquote></p><p>The deal values the combined company at about $511 million including debt, according to a statement Wednesday that confirmed an earlier Bloomberg News report. Existing Suneva backers will invest $10 million in a private investment in public equity deal, according to Chief Executive Officer Pat Altavilla.</p><p><blockquote>根据周三的一份声明，该交易对合并后公司的估值约为5.11亿美元，包括债务，该声明证实了彭博新闻社早些时候的报道。Suneva首席执行官帕特·阿尔塔维拉(Pat Altavilla)表示，Suneva现有支持者将投资1000万美元进行私募股权交易。</blockquote></p><p>The combined company will operate as Suneva Medical and trade on the New York Stock Exchange under the symbol RNEW, according to the statement.</p><p><blockquote>声明称，合并后的公司将在纽约证券交易所以Suneva Medical and trade的名义运营，代码为RNEW。</blockquote></p><p>“It’s a wonderful way for Suneva to become fully capitalized to take advantage of the remarkable capabilities of the capital markets and to grow the business the way we intend to,” Altavilla said in an interview.</p><p><blockquote>阿尔塔维拉在接受采访时表示：“对于Suneva来说，这是一个充分资本化的好方法，可以利用资本市场的卓越能力，并按照我们打算的方式发展业务。”</blockquote></p><p>Suneva expects to grow by developing new products like a hair-restoration offering, acquiring businesses and catering to more men and millenials, she said.</p><p><blockquote>她说，Suneva希望通过开发头发修复产品等新产品、收购企业以及迎合更多男性和千禧一代来实现增长。</blockquote></p><p>Suneva specializes in so-called regenerative aesthetics that use the body’s own collagen to improve the skin’s appearance. Its biggest product is Bellafill, a Food and Drug Administration-approved dermal filler that is advertised to “smooth smile lines” and reduce the appearance of acne scars. Its products and procedures, all of which Altavilla said have a “biostimulatory component” are sold into medical offices and conducted by doctors, nurses or nurse practitioners. It has about 1600 customers, she said.</p><p><blockquote>Suneva专注于所谓的再生美学，利用身体自身的胶原蛋白来改善皮肤的外观。其最大的产品是Bellafill，这是一种美国食品药品监督管理局批准的真皮填充物，宣传可以“抚平笑纹”并减少痤疮疤痕的出现。阿尔塔维拉表示，其产品和程序都含有“生物刺激成分”，这些产品和程序都出售给医疗办公室，并由医生、护士或执业护士进行。她说，它有大约1600名顾客。</blockquote></p><p>Viveon Health Acquisition, a special purpose acquisition company, or SPAC, raised $201 million in its initial public offering in 2020.</p><p><blockquote>Viveon Health Acquisition是一家特殊目的收购公司(SPAC)，在2020年首次公开募股中筹集了2.01亿美元。</blockquote></p><p>“People are looking toward more natural solutions,” Altavilla said. “The regenerative properties of these procedures allow them to have better longer-lasting results.”</p><p><blockquote>“人们正在寻找更自然的解决方案，”阿尔塔维拉说。“这些程序的再生特性使它们能够获得更好、更持久的结果。”</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/aesthetics-firm-suneva-said-talks-010000738.html\">Bloomberg</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VHAQ":"Viveon Health Acquisition Corp"},"source_url":"https://finance.yahoo.com/news/aesthetics-firm-suneva-said-talks-010000738.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199219279","content_text":"(Bloomberg) -- Suneva Medical Inc., which sells beauty and anti-aging products to doctors’ offices, has agreed to go public through a merger with blank-check company Viveon Health Acquisition Corp.The deal values the combined company at about $511 million including debt, according to a statement Wednesday that confirmed an earlier Bloomberg News report. Existing Suneva backers will invest $10 million in a private investment in public equity deal, according to Chief Executive Officer Pat Altavilla.The combined company will operate as Suneva Medical and trade on the New York Stock Exchange under the symbol RNEW, according to the statement.“It’s a wonderful way for Suneva to become fully capitalized to take advantage of the remarkable capabilities of the capital markets and to grow the business the way we intend to,” Altavilla said in an interview.Suneva expects to grow by developing new products like a hair-restoration offering, acquiring businesses and catering to more men and millenials, she said.Suneva specializes in so-called regenerative aesthetics that use the body’s own collagen to improve the skin’s appearance. Its biggest product is Bellafill, a Food and Drug Administration-approved dermal filler that is advertised to “smooth smile lines” and reduce the appearance of acne scars. Its products and procedures, all of which Altavilla said have a “biostimulatory component” are sold into medical offices and conducted by doctors, nurses or nurse practitioners. It has about 1600 customers, she said.Viveon Health Acquisition, a special purpose acquisition company, or SPAC, raised $201 million in its initial public offering in 2020.“People are looking toward more natural solutions,” Altavilla said. “The regenerative properties of these procedures allow them to have better longer-lasting results.”","news_type":1,"symbols_score_info":{"VHAQ":0.9}},"isVote":1,"tweetType":1,"viewCount":2769,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":3,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/694257889"}
精彩评论